13F Filings History of BONTEMPO OHLY CAPITAL MGMT LLC

Latest 13F report
Q4 2025 - 13 Feb 2026
Value $
$232,129,768
Signature - Title
Ormand A. Bontempo - President/Member
Location
Bethesda, MD
Summary
This page shows a list of all the recent 13F filings made by BONTEMPO OHLY CAPITAL MGMT LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BONTEMPO OHLY CAPITAL MGMT LLC reported 31 stock holdings with total value $232,129,768 as of Q4 2025. Top holdings included EFA, IVV, DG, JNJ, and CSCO.

Notify me when BONTEMPO OHLY CAPITAL MGMT LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 31 $232,129,768 +$165,356 -$1,324,937 -$1,159,581 EFA, IVV, DG, JNJ, CSCO 13F-HR 13 Feb 2026, 15:52
Q3 2025 31 $230,854,475 +$378,441 -$409,269 -$30,828 EFA, IVV, FAST, DG, NOC 13F-HR 14 Nov 2025, 17:14
Q2 2025 31 $220,835,009 +$7,183,922 -$1,392,114 +$5,791,808 EFA, IVV, DG, CSCO, FAST 13F-HR 13 Aug 2025, 18:10
Q1 2025 31 $207,368,555 +$42,244,126 -$44,126,082 -$1,881,956 EFA, IVV, DG, PAYX, JNJ 13F-HR 05 Jun 2025, 17:50
Q4 2024 34 $205,472,708 +$55,736 -$3,320,315 -$3,264,579 IVV, EFA, GRMN, FAST, PAYX 13F-HR 14 Feb 2025, 16:17
Q3 2024 35 $219,170,346 +$2,558,168 -$149,615 +$2,408,553 IVV, EFA, GRMN, LMT, LOW Restatement 15 Nov 2024, 14:23
Q2 2024 34 $200,023,308 +$899,750 -$590,276 +$309,474 IVV, EFA, GRMN, TXN, GD 13F-HR 14 Aug 2024, 17:39
Q1 2024 34 $205,006,530 +$12,305,684 -$27,820,950 -$15,515,266 IVV, EFA, FAST, TGT, GRMN 13F-HR 15 May 2024, 17:17
Q4 2023 36 $206,339,169 +$5,621,885 -$437,782 +$5,184,103 IVV, EFA, INTC, FAST, GRMN 13F-HR 14 Feb 2024, 16:21
Q3 2023 35 $182,480,737 +$144,121 -$14,713,219 -$14,569,098 IVV, EFA, INTC, CMCSA, FAST 13F-HR 14 Nov 2023, 17:04
Q2 2023 37 $205,401,047 +$1,320,440 -$442,713 +$877,727 IVV, EFA, FAST, LOW, CLX 13F-HR 14 Aug 2023, 16:35
Q1 2023 37 $200,989,531 +$49,028,331 -$20,537,091 +$28,491,240 IVV, EFA, GIS, CSCO, FAST 13F-HR 15 May 2023, 17:06
Q4 2022 30 $168,229,361 +$747,836 -$1,037,933 -$290,097 IVV, EFA, CI, LMT, GIS 13F-HR 14 Feb 2023, 17:07
Q3 2022 31 $150,934,000 +$1,890,604 -$105,908 +$1,784,696 IVV, EFA, CI, ADP, GIS 13F-HR 14 Nov 2022, 16:20
Q2 2022 30 $161,708,000 +$649,740 -$964,069 -$314,329 IVV, EFA, LMT, GIS, CI 13F-HR 15 Aug 2022, 17:33
Q1 2022 32 $181,868,000 +$21,063,683 -$29,586,308 -$8,522,625 IVV, EFA, LMT, GD, ADP 13F-HR 16 May 2022, 16:02
Q4 2021 33 $193,864,000 +$2,881,917 -$1,088,682 +$1,793,235 IVV, EFA, ADP, PAYX, CSCO 13F-HR 14 Feb 2022, 15:51
Q3 2021 32 $178,714,000 +$49,102 -$1,799,301 -$1,750,199 IVV, EFA, ADP, CSCO, GD 13F-HR 15 Nov 2021, 16:03
Q2 2021 32 $184,224,000 +$360,565 -$1,973,037 -$1,612,472 IVV, EFA, ADP, CSCO, GD 13F-HR 16 Aug 2021, 15:13
Q1 2021 32 $178,797,000 +$25,472,877 -$24,900,573 +$572,304 IVV, EFA, WBA, CSCO, ADP 13F-HR 17 May 2021, 15:05
Q4 2020 34 $166,787,000 +$3,026,551 -$1,107,734 +$1,918,817 IVV, EFA, SASR, FAST, ETN 13F-HR 16 Feb 2021, 15:28
Q3 2020 33 $146,950,000 +$1,535,229 -$1,558,771 -$23,542 IVV, EFA, SASR, CLX, FAST 13F-HR 16 Nov 2020, 12:51
Q2 2020 33 $141,418,000 +$12,909,905 -$8,298,783 +$4,611,122 IVV, EFA, SASR, CLX, FAST 13F-HR 14 Aug 2020, 16:24
Q1 2020 32 $120,259,000 +$23,756,400 -$27,499,014 -$3,742,614 IVV, EFA, REVB, CLX, GIS 13F-HR 15 May 2020, 16:11
Q4 2019 31 $150,020,000 +$2,110,678 -$335,440 +$1,775,238 IVV, EFA, KO, ADP, LMT 13F-HR 14 Feb 2020, 11:40
Q3 2019 30 $140,459,000 +$3,085,309 -$2,477,624 +$607,685 IVV, EFA, KO, HSY, LMT 13F-HR 14 Nov 2019, 15:33
Q2 2019 29 $138,021,000 +$2,137,823 -$51,843 +$2,085,980 IVV, EFA, CSCO, ADP, KO 13F-HR 13 Aug 2019, 16:49
Q1 2019 29 $133,629,000 +$15,043,397 -$29,207,658 -$14,164,261 IVV, EFA, CSCO, ADP, XOM 13F-HR 15 May 2019, 18:13
Q4 2018 33 $134,850,000 +$2,895,656 -$365,327 +$2,530,329 IVV, EFA, PFE, CSCO, VZ 13F-HR 14 Feb 2019, 16:26
Q3 2018 33 $147,538,000 +$15,876,725 -$3,054,000 +$12,822,725 IVV, EFA, CSCO, PFE, ADP 13F-HR 14 Nov 2018, 16:39
Q2 2018 29 $127,567,000 +$1,431,413 -$10,980 +$1,420,433 IVV, EFA, CSCO, PFE, ADP 13F-HR 14 Aug 2018, 17:29
Q1 2018 29 $125,264,000 +$59,486 -$1,408,664 -$1,349,178 IVV, EFA, CSCO, PFE, KO 13F-HR 15 May 2018, 17:22
Q4 2017 29 $128,226,000 +$16,410,463 -$21,172,496 -$4,762,033 IVV, EFA, CSCO, PFE, VZ 13F-HR 14 Feb 2018, 14:13
Q3 2017 30 $129,051,000 +$81,651 -$528,302 -$446,651 IVV, EFA, CSCO, PFE, KO 13F-HR 14 Nov 2017, 18:20
Q2 2017 30 $123,957,000 +$54,701 -$2,811,788 -$2,757,087 IVV, EFA, KO, CSCO, PFE 13F-HR 14 Aug 2017, 17:40
Q1 2017 30 $124,907,000 +$22,280,282 -$24,455,599 -$2,175,317 IVV, EFA, CSCO, IBM, PG 13F-HR 15 May 2017, 13:33
Q4 2016 31 $122,465,000 +$2,242,099 -$412,448 +$1,829,651 IVV, EFA, IBM, VZ, Merck & Co Inc Com 13F-HR 14 Feb 2017, 16:58
Q3 2016 29 $119,556,000 +$1,821,634 -$1,184,901 +$636,733 IVV, EFA, Merck & Co Inc Com, CSCO, VZ 13F-HR 14 Nov 2016, 17:43
Q2 2016 29 $115,878,000 +$151,105 -$680,304 -$529,199 IVV, EFA, VZ, WMT, Merck & Co Inc Com 13F-HR 05 Aug 2016, 16:42
Q1 2016 29 $113,871,000 +$29,122,950 -$22,056,653 +$7,066,297 IVV, EFA, VZ, WMT, IBM 13F-HR 16 May 2016, 16:37
Q4 2015 28 $105,406,000 +$289,190 -$225,478 +$63,712 IVV, EFA, GE, T, PFE 13F-HR 16 Feb 2016, 16:54
Q3 2015 28 $99,070,000 +$3,442,008 -$14,310 +$3,427,698 IVV, EFA, GE, PFE, T 13F-HR 16 Nov 2015, 17:11
Q2 2015 27 $103,208,000 +$17,634 -$838,636 -$821,002 IVV, EFA, GE, T, PFE 13F-HR 14 Aug 2015, 13:03
Q1 2015 27 $105,028,000 +$19,651,103 -$19,799,547 -$148,444 IVV, EFA, PFE, GE, VZ 13F-HR 14 May 2015, 16:10
Q4 2014 27 $103,257,000 $0 $0 $0 IVV, EFA, INTC, CSCO, PFE 13F-HR 18 Feb 2015, 10:42